TR 15 focuses on validation of tangential flow filtration processes used to manufacture therapeutic proteins and polypeptides produced from recombinant or non-recombinant expression systems that can be characterized with appropriate analytical methods.
PDA technical documents undergo external review to provide high quality, valuable resources for the pharmaceutical industry. Reviewers from all levels of experience and geographies are encouraged to participate to ensure the documents are accessible and relevant to a wide audience.
- Process Engineering
- Upload CV
- Current PDA Members only